HemaSphere (May 2023)

P31 SINGLE-AGENT BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: FINAL ANALYSIS OF THE DREAMM-2 TRIAL

  • A. Nooka,
  • A. Cohen,
  • H. Lee,
  • A. Badros,
  • A. Suvannasankha,
  • N. Callander,
  • A. Abdallah,
  • S. Trudel,
  • A. Chari,
  • E. Libby,
  • M. Chaudhry,
  • M. Hultcrantz,
  • K.M. Kortüm,
  • P. Richardson,
  • R. Popat,
  • D. Sborov,
  • S. Hakim,
  • E. Lewis,
  • B. Bhushan,
  • B. Gorsh,
  • I. Gupta,
  • J. Opalinska,
  • S. Lonial

DOI
https://doi.org/10.1097/01.HS9.0000936252.25785.17
Journal volume & issue
Vol. 7, no. S2
pp. 27 – 28

Abstract

Read online

No abstracts available.